Elbasvir/Grazoprevir for HCV Infection in Russia: A Randomized Trial.

Konstantin ZhdanovVasily A IsakovEduard BurnevichSvetlana KizhloIgor BakulinVadim PokrovskyLiwen LiangPeggy HwangRohit TalwaniBarbara A HaberMichael N Robertson

Published in: Hepatic medicine : evidence and research (2020)

Elbasvir/grazoprevir for 12 weeks was highly effective in treatment-naive Russian individuals with HCV genotype 1b infection.

Keyphrases